Lv1
50 积分 2025-09-06 加入
Drug development in MZL: caring for the forgotten child
5小时前
求助中
The treatment of marginal zone lymphoma
5小时前
已完结
The biology of marginal zone lymphoma subtypes: challenge and relevance of classification
5小时前
求助中
A foundation model for breast and lung cancer screening using non-contrast computed tomography
1个月前
已关闭
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma
2个月前
已完结
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma
2个月前
已完结
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
2个月前
已关闭
Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?
2个月前
已关闭
Jaworek CP, Bröckelmann PJ. Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?
2个月前
已关闭
Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study
4个月前
已关闭
皖公网安备34019202002308
